Expression of Platelet-Activating Factor Receptor: A Novel Prognosticator in Patients with Hepatocellular Carcinoma following Hepatectomy
暂无分享,去创建一个
[1] F. Caire,et al. Platelet‐activating factor and human meningiomas , 2006, Neuropathology and applied neurobiology.
[2] F. Labrousse,et al. Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. , 2006, World journal of gastroenterology.
[3] D. Lev,et al. Platelet-activating Factor Mediates MMP-2 Expression and Activation via Phosphorylation of cAMP-response Element-binding Protein and Contributes to Melanoma Metastasis* , 2006, Journal of Biological Chemistry.
[4] S. Theocharis,et al. Effect of platelet‐activating factor (PAF) receptor antagonist (BN52021) on acetaminophen‐induced acute liver injury and regeneration in rats , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[5] G. Camussi,et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. , 2005, The American journal of pathology.
[6] Yu-Ying Chao,et al. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells. , 2004, Cellular signalling.
[7] S. A. Harvey,et al. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis , 2004, Gut.
[8] F. Sigaux,et al. Glycoprotein 170 Induces Platelet-Activating Factor Receptor Membrane Expression and Confers Tumor Cell Hypersensitivity to NK-Dependent Cell Lysis1 , 2004, The Journal of Immunology.
[9] N. Bazan,et al. Activation of Platelet-activating Factor Receptor-coupled Gαq Leads to Stimulation of Src and Focal Adhesion Kinase via Two Separate Pathways in Human Umbilical Vein Endothelial Cells* , 2004, Journal of Biological Chemistry.
[10] J. Stankova,et al. Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor* , 2003, Journal of Biological Chemistry.
[11] C. Gandhi,et al. Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. , 2003, Journal of hepatology.
[12] S. Chakrabarty,et al. Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells , 2003, Oncogene.
[13] G. Camussi,et al. Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet‐activating factor synthesis , 2002, International journal of cancer.
[14] G. Koh,et al. Nuclear Factor κB Dependency of Platelet-activating Factor-induced Angiogenesis , 2002 .
[15] M. Mareel,et al. Suppression of Cellular Invasion by Activated G-Protein Subunits Gαo, Gαi1, Gαi2, and Gαi3 and Sequestration of Gβγ , 2001 .
[16] Y. Denizot,et al. Is there a role of platelet-activating factor in human lung cancer? , 2001, Lung cancer.
[17] S Russo,et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. , 2000, The American journal of pathology.
[18] F. Sigaux,et al. Interferon-γ–induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis , 2000 .
[19] T. Okamoto,et al. Participation of platelet‐activating factor in the lipopolysaccharide‐induced liver injury in partially hepatectomized rats , 1999, Hepatology.
[20] M. Kagnoff,et al. Human intestinal epithelial cells express receptors for platelet-activating factor. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[21] A. Sapino,et al. Potential angiogenic role of platelet-activating factor in human breast cancer. , 1998, The American journal of pathology.
[22] M. Mareel,et al. Inhibition by Platelet-activating Factor of Src- and Hepatocyte Growth Factor-dependent Invasiveness of Intestinal and Kidney Epithelial Cells , 1998, The Journal of Biological Chemistry.
[23] S. Sato,et al. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. , 1998, The Journal of investigative dermatology.
[24] T. Shanley,et al. Role of Kupffer cells in gut ischemia/reperfusion‐induced hepatic microvascular dysfunction in mice , 1997, Hepatology.
[25] Takao Shimizu,et al. Platelet-activating Factor (PAF) Induces Growth Stimulation, Inhibition, and Suppression of Oncogenic Transformation in NRK Cells Overexpressing the PAF Receptor* , 1997, The Journal of Biological Chemistry.
[26] S. Hirohashi,et al. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver. , 1997, Journal of hepatology.
[27] D. Remick,et al. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. , 1997, The Biochemical journal.
[28] S. Im,et al. Augmentation of tumor metastasis by platelet-activating factor. , 1996, Cancer research.
[29] S. Nakamura,et al. Involvement of platelet‐activating factor in cytokine production and neutrophil activation after hepatic ischemia‐reperfusion , 1996, Hepatology.
[30] Takao Shimizu,et al. Platelet-activating factor receptor: gene expression and signal transduction. , 1995, Biochimica et biophysica acta.
[31] G. Camussi,et al. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.
[32] E. Nishida,et al. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.
[33] M. Olson,et al. Inflammation and platelet‐activating factor production during hepatic ischemia/reperfusion , 1992, Hepatology.
[34] D. Hanahan,et al. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.
[35] C. Gandhi,et al. 89 Kupffer cells are a major source of increased platelet activating factor in the CCL-induced cirrhotic rat liver , 2003 .
[36] S. Ishii,et al. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. , 2000, Progress in lipid research.
[37] J. Miyazaki,et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor , 1997, The EMBO journal.